Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Chugai to Copromote Otsuka's Antiplatelet Agent Pletaal
December 25, 2006
- REGULATORY NEWS IN BRIEF
December 25, 2006
- Pfizer to Continue Launching Series of New Drugs: President Iwasaki
December 25, 2006
- Nichi-Iko Providing Third-party Data on Its Products
December 18, 2006
- US-Japan Gap in Approval Time Grew in 2005: OPIR
December 18, 2006
- ON THE MOVE
December 18, 2006
- Case Report on Problems with Generics Presented
December 18, 2006
- BUSINESS NEWS IN BRIEF
December 18, 2006
- Synix to Launch Improved Cancer Treatment Database
December 18, 2006
- ADVATE to Reach Japanese Hemophiliacs: Baxter
December 18, 2006
- Astellas Announces VISION 2015 Management Vision
December 18, 2006
- AstraZeneca Aims to Enter Domestic Top 10 in 2007
December 18, 2006
- Banyu Reports on Leukotriene Antagonists in Asthma Treatment in New GINA Guidelines
December 18, 2006
- MEDICAL DEVICE NEWS IN BRIEF
December 18, 2006
- NEW PRODUCTS
December 18, 2006
- NEW PRODUCTS
December 18, 2006
- REGULATORY NEWS IN BRIEF
December 18, 2006
- NIBIO Partnership Forum
December 18, 2006
- Tokai Univ. Symposium on Transfer of Technology
December 18, 2006
- Prime Minister Expresses High Hopes of Pharmaceutical Industry
December 18, 2006
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…